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Background: The Candida albicans cell wall is the first point of contact with the host, and its outer surface is
heavily enriched in mannoproteins modified through the addition of N- and O-mannan. Previous work, using
mutants with gross defects in glycosylation, has clearly identified the importance of mannan in the host-pathogen
interaction, immune recognition and virulence. Here we report the first analysis of the MNN1 gene family, which
contains six members predicted to act as α-1,3 mannosyltransferases in the terminal stages of glycosylation.
Findings: We generated single null mutants in all members of the C. albicans MNN1 gene family, and disruption of
MNN14 led to both in vitro and in vivo defects. Null mutants in other members of the family demonstrated no
phenotypic defects, suggesting that these members may display functional redundancy. The mnn14Δ null mutant
displayed hypersensitivity to agents associated with cell wall and glycosylation defects, suggesting an altered cell
wall structure. However, no gross changes in cell wall composition or N-glycosylation were identified in this mutant,
although an extension of phosphomannan chain length was apparent. Although the cell wall defects associated
with the mnn14Δ mutant were subtle, this mutant displayed a severe attenuation of virulence in a murine infection
model.
Conclusion: Mnn14 plays a distinct role from other members of the MNN1 family, demonstrating that specific
N-glycan outer chain epitopes are required in the host-pathogen interaction and virulence.
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Background
Candida albicans is the most common opportunistic
fungal pathogen of humans causing superficial infections
of the mucosa, and life threatening systemic infections
in immunocompromised and severely ill patients [1-3].
The fungal cell wall is a dynamic structure required for
maintaining cell shape and providing protection from
changes in the extracellular environment. In addition,
the cell wall acts as the first point of contact with the
host and plays an essential role in the host-fungal inter-
action. The cell wall is composed of an inner skeletal
layer of β-glucans and chitin, decorated with an outer
layer enriched in mannoproteins that are heavily post-
translationally modified through the addition of N- and* Correspondence: s.bates@ex.ac.uk
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reproduction in any medium, provided the orO-linked mannans [4-6]. These mannans have been
shown to play a vital role in cell wall integrity, adhesion
and virulence, and constitute one of the main C. albicans
pathogen associated molecular patterns (PAMPs) recog-
nised by the host innate immune system [7-16].
In C. albicans structural studies of O-mannan have
shown that it typically consists of one to five α1,2-linked
mannose residues attached to serine or threonine, and
that these are required for full virulence [11,12]. In
addition studies using anti-β-mannan specific antibodies
have demonstrated that O-mannan may also contain
β1,2-linked mannose residues [13], presumably added by
members of the BMT family [14]. This is different to
Saccharomyces cerevisiae where O-mannan consists of
one to two α1,2-linked mannose residues capped with
α1,3-linked mannose residues transferred by members of
the Mnn1 family. N-glycosylation is initiated in the
endoplasmic reticulum (ER) with the transfer of the
N-mannan precursor (Glc3Man9GlcNAc2) to specifictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Homology of MNN1 gene family products
Protein % Identity (% similarity)a
Mnn1 Mnn12 Mnn13 Mnn14 Mnn15 Mnn16
Mnn1 100% - - - - -
(100%)
Mnn12 43.8% 100% - - - -
(60.7%) (100%)
Mnn13 42.8% 37.7% 100% - - -
(62.0%) (55.9%) (100%)
Mnn14 31.3% 32.9% 32.2% 100% - -
(47.3%) (49.34%) (49.1%) (100%)
Mnn15 24.3% 24.8% 25.9% 26.1% 100% -
(39.5%) (39.6%) (41.8%) (42.8%) (100%)
Mnn16 21.9% 19.0% 21.2% 24.6% 21.4% 100%
(35.4%) (31.8%) (36.1%) (39.8%) (36.5%) (100%)
a Identity and similarity were calculated over the full length of the protein.
Figure 1 Phylogram of the C. albicans MNN1 gene family. A
multiple sequence alignment and phylogram of the six MNN1
orthologues was generated in Clustal Omega (version 1.1.0).
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processed by ER resident glycosidases to form the mature
Man8GlcNAc2 core conserved across eukaryotes [10]. In
C. albicans as well as other fungi, the core is then exten-
sively modified through outer chain elaboration as the
protein passes through the Golgi [7,14,16,17]. Outer chain
elaboration is initiated through the addition of a single
α1,6-linked mannose residue to the core by Och1 [7], and
the subsequent extension of the α1,6-backbone by the se-
quential action of the mannan polymerase I and II enzyme
complexes [17,18]. The α1,6-backbone is then further
elaborated with side chains, which in C. albicans consists
of α1,2-, α1,3-, and β1,2-linked mannose residues [14,16,19].
In addition both N-mannan and O-mannan structures can
be further modified through the addition of phospho-
mannan, which in C. albicans consists of a chain of β1,
2-linked mannose residues attached through a phospho-
diester linkage [10,20,21].
Previous work has clearly identified outer chain N-gly-
cosylation as an important factor in the host-fungal
interaction and virulence [7,8,10,14-16]. However, most
work to date has focused on the early stages of outer
chain elaboration where the mutants display gross de-
fects in glycosylation. In S. cerevisiae the MNN1/2 family
contains genes involved in the elaboration of O- and N-
mannan; in particular the MNN1 sub-family encodes
α1,3-mannosyltranferases important for the addition of
the terminal mannose residues in O- and N-mannan
[22,23]. In C. albicans we have identified six MNN1 fam-
ily members and here we report the first analysis of this
gene family in C. albicans. Null mutants in most of its
members displayed no alteration of phenotype, sugges-
ting possible functional redundancy. However, the mnn14Δ
mutant, whilst displaying only subtle cell wall changes,
was severely attenuated in virulence, demonstrating
that specific glycans are important in the host-fungal
interaction.
Results and discussion
Analysis and disruption of C. albicans MNN1 family
members
Our analysis of assembly 21 of the C. albicans genome
identified a gene family of 12 members homologous to
the S. cerevisiae MNN1/2 family. Similar to S. cerevisiae
this family could be divided into two subfamilies based
on homology to either MNN1 or MNN2. Six mem-
bers of the C. albicans MNN1 family were identified
(orf19.4279, orf19.4900, orf19.4270, orf19.6996, orf19.753
and orf19.6313) and designated MNN1, MNN12, MNN13,
MNN14, MNN15 and MNN16. The proteins encoded by
this family share 19-44% homology between members
(Table 1, Figure 1) and a characteristic type II membrane
protein topology, with a single N-terminal membrane
spanning region (17–19 amino acids) preceded by a short(5–13 amino acid) cytosolic tail. All Mnn1 family mem-
bers, except Mnn16, contain the conserved DxD motif
known to be important for substrate and co-factor binding
[24], suggesting that Mnn16 may have altered function-
ality. The MNN1 family shows varying numbers in the
sequenced CUG clade species [25] with C. albicans,
Candida tropicalis and Candida parapsilosis enco-
ding 6, 8, and 4 members respectively, compared to the
non-pathogenic or infrequent pathogens, Lodderomyces
elongisporus, Candida guilliermondii, Candida lusita-
niae, and Debaryomyces hansenii which have 5, 4, 3
and 3 members respectively.
Single null mutants in all MNN1 family members were
generated through sequential gene deletion, and the
URA3 marker was introduced at the RPS1 locus to avoid
problems associated with its ectopic expression. To con-
trol against second site mutations two independently
constructed null mutants were generated for each mem-
ber of the family and shown to display comparable phe-
notypes. The mutants all had growth rates similar to the
wild type control strain (doubling time 1.4 h) in SC
Bates et al. BMC Research Notes 2013, 6:294 Page 3 of 9
http://www.biomedcentral.com/1756-0500/6/294medium at 30°C, and displayed no morphological de-
fects, such as cellular aggregation, which has previously
been seen in mutants displaying glycosylation defects
[7-10,16]. In terms of hyphal development all of the
MNN1 family mutants underwent morphogenesis in re-
sponse to 20% serum. However, the mnn14Δ null mutant
displayed a defect in response to the weaker hypha-
inducing signal of pH and temperature, with cells con-
stitutively forming pseudohyphae in response to Lee’s
medium at pH 6.5 and 37°C. In addition, the mnn14Δ null
mutant also failed to form filaments on solid spider
medium (Figure 2).
Glycosylation defects in the MNN1 family mutants
The effect of disruption of the MNN1 family members
on N-linked glycosylation was initially assessed through
monitoring the electrophoretic mobility of secreted
Hex1 (β-N-acetylhexosaminidase) by activity staining
following native gel electrophoresis [7]. None of the
MNN1 family mutants displayed the increased electro-
phoretic mobility of Hex1 that is normally associated
with a deficiency in N-glycosylation, as demonstrated by
och1Δ and pmr1Δ mutants [7,8], indicating no gross
N-glycosylation defects in the MNN1 family mutants
(Figure 3A). However, the mnn14Δ null mutant instead
demonstrated a noticeable decrease in Hex1 mobility
following native gel electrophoresis (Figure 3A). This de-
crease in electrophoretic mobility could be suggestive of
an increased level of glycosylation of Hex1 in this mu-
tant. Alternatively, an alteration in the level, or extent of,
phosphomannan modification could affect the surface
charge of Hex1, which would impact on its mobility in a
native gel.
To screen for more subtle glycosylation defects, and to
discount the impact of altered surface charge on electro-
phoretic mobility, we epitope tagged Hex1 with V5-
6xHis in the null mutants and conducted Western blot
analysis of Hex1-V5-6xHis following standard denatur-
ing gel electrophoresis. Following Western blot analysisFigure 2 Cell and colony morphology of MNN1 family mutants. Cell m
in Lee’s at pH6.5 for 6 h (B). Scale bar, 10 μm. (C) Colony morphology afteHex1-V5-6xHis was apparent in both an unmodified
(67 kDa) and a heavily glycosylated (~125 kDa) form in
soluble protein extracts. In the pmr1Δ mutant, which is
known to display glycosylation defects [8], the gly-
cosylated form of Hex1-V5-6xHis demonstrated a clear
increase in electrophoretic mobility characteristic of this
mutant’s gross defect in glycosylation. However, no
change in electrophoretic mobility of the glycosylated
form of Hex1-V5-6xHis was observed for any of the
MNN1 family mutants (Figure 3B), demonstrating that
none of these mutants displayed a gross defect in N-gly-
cosylation. In addition, this would suggest that the de-
creased electrophoretic mobility of Hex1 seen in the
mnn14Δ null mutant following native gel electrophoresis
and activity staining is likely to be due to differences in
the proteins surface charge and not the overall level of
glycosylation.
Phosphomannan, attached to O- and N- mannan through
a phosphodiester linkage, can affect the native charge of
proteins. The overall level of phosphomannan incorpor-
ation into the cell wall can be estimated through the use
of the phthalocyanine dye, Alcian Blue, which binds to
phosphorylated polysaccharides [20,26]. None of the
MNN1 family null mutants displayed altered Alcian Blue
binding (Table 2), indicating that each displays a similar
level of phosphomannan at the cell surface. This would
also suggest that the decreased native gel mobility of Hex1
from mnn14Δ cells was not due to a decrease in the over-
all level of phosphomannan present. The surface charge
associated with phosphomannan is also dependent on the
chain length of β1,2-mannose residues present [26,27].
Therefore, we also directly analysed phosphomannan
structure in the MNN1 family null mutants by TLC. The
wild type strain, and the majority of the mutants,
displayed the expected profile of one to five β1,2-mannose
residues. However, the mnn14Δ null mutant clearly
displayed an altered profile with a preponderance for lon-
ger chains and an increased chain length of one to eight
residues (Figure 3C). Extension of the phosphomannanorphology after growth at 37°C in 20% serum for 4 h (A) and at 37°C
r 6 days growth at 30°C on solid Spider medium. Scale bar, 1 mm.
Figure 3 Glycosylation defects in C. albicans MNN1 family null mutants. The extent of N-glycosylation was determined by activity staining of
Hex1 (β-N-acetylhexosaminidase) after protein samples were separated by non-denaturing gel electrophoresis (A). The continuous and dotted
lines indicate the normal and decreased electrophoretic mobility of Hex1 respectively. The degree of N-glycosylation modification was also
determined by western blot analysis of Hex1-V5-6× His tagged strains (B). Hex1-V5-6× His is apparent in both an unmodified (67 kDa) and a
heavily glycosylated (~125 kDa) form. Acid-labile phosphomannan (C) and β-eliminated O-mannan (D) were released from [2-3H] mannose-
labelled cells and separated by TLC. Samples are as follows: lane 1, wild type; lane 2, mnn1Δ; lane 3, mnn12Δ; lane 4, mnn13Δ; lane 5, mnn14Δ; lane 6,
mnn15Δ; lane 7, mnn16Δ; lane 8, och1Δ; lane 9, pmr1Δ; lane 10, mnt1Δ-mnt2Δ.
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role in the modulation of cell surface charge, with longer
phosphomannan chains resulting in the loss of charge
demonstrated by an increase in hydrophobicity of the cell
wall [26,27]. Therefore the increase in the degree of
phosphomannan extension seen in the mnn14Δ null mu-
tant could reduce the surface charge associated with Hex1
which would then explain its decreased mobility under
native conditions even though its overall level of modifica-
tion is not grossly alerted.
The structure of O-linked mannans was also assessed by
TLC and no significant differences were observed in any
of the MNN1 family mutants (Figure 3D). This is consist-
ent with the previous finding that Mnt1 and Mnt2 are theTable 2 Alcian blue binding
Strain genotype Alcian blue binding ± SD
(μg bound/OD600 1.0)
Wild type 183.1 ± 8.7
mnn1Δ 148.2 ± 21.6
mnn12Δ 143.3 ± 37.4
mnn13Δ 175.3 ± 7.4
mnn14Δ 181.9 ± 3.9
mnn15Δ 184.1 ± 2.6
mnn16Δ 191.1 ± 6.7
och1Δ 25.2 ± 2.2principal enzymes involved in the extension of O-glycans,
and that C. albicans lacks α1,3-linked residues in its
O-mannan [11].
Cell wall associated defects
To examine cell wall integrity we screened the MNN1
family null mutants for sensitivity to a range of cell wall
perturbing agents. The mnn14Δ null mutant was clear-
ly hypersensitive to SDS, tunicamycin, and hygromy-
cin B which is characteristic of glycosylation mutants
(Figure 4). However, no increase in sensitivity was seen
to the cell wall perturbing agent Calcofluor White,
suggesting that the mnn14Δ null mutant does not have a
defect in the general robustness of the cell wall. No
other family members displayed altered sensitivity to any
of the compounds tested. Changes in cell wall structure
were also assessed through HPLC sugar composition
analysis, but no gross alteration in the relative propor-
tions of the three main cell wall polysaccharides (glucan,
mannan and chitin) was identified for any of the MNN1
family null mutants (data not shown).
Defects in the initiation of O-glycosylation or treat-
ment with tunicamycin, which inhibits N-glycosylation,
have previously been shown to impair biofilm formation
[28,29]. We therefore screened the MNN1 family mu-
tants for defects in biofilm formation, using a 96 well
microplate model and XTT reduction assay to measure
metabolic activity of the cells within the biofilm. As pre-
Figure 4 Sensitivity of C. albicans mnn14Δ null mutant to cell wall perturbing agents. The sensitivities of the wild type (closed squares) and
Camnn14Δ null mutant (open squares) to cell wall perturbing agents were determined by a broth microdilution method. The agents to which the
Camnn14Δ null mutant displayed hypersensitivity are shown (hygromycin B, tunicamycin, and SDS).
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N-linked glycosylation, displayed a severe biofilm defect
demonstrating a 90% reduction in biofilm formation at
48 h, therefore confirming the importance of N-mannan
in biofilm formation. In addition the mnt1Δ-mnt2Δ dou-
ble mutant [11], which lacks the 4 terminal mannose
residues in O-mannan, also displayed a clear biofilm de-
fect (80% reduction). This indicates that the extension of
O-mannan, in addition to the initiation of its synthesis,
is also important for biofilm formation. However, none
of the MNN1 family single mutants displayed a signifi-
cant defect in biofilm formation (Figure 5). This lack of
a phenotypic defect may be due to functional redun-
dancy in the MNN1 family. Alternatively, it may suggest
that only gross N-glycosylation defects impact upon bio-
film formation rather than its being dependent on spe-
cific epitopes. Indeed, the pmr1Δ null mutant, which
displays both O- and N-linked glycosylation defects, but
to a lesser extent than the individual defects seen in the
och1Δ or mnt1Δ-mnt2Δ mutants, only displays a subtle
biofilm defect (40% reduction at 48 h). Therefore,
biofilm formation is dependent both on correct O-Figure 5 Biofilm formation of MNN1 family mutants. Biofilm
formation was assessed in 96 well plates using a tetrazolium salt
(XTT) reduction assay following growth in SC medium for 24 h
(closed bars) and 48 h (open bars).glycosylation and the overall level of N-glycosylation,
presumably through their impact on cellular interactions.
Host-pathogen interaction and virulence
As cell wall mannan has been shown to play an import-
ant role in the stimulation of the host response [15] we
tested the ability of the null mutants to induce cytokine
production by human PBMCs. All the MNN1 family
mutants were as potent at stimulating TNFα and IL-6
production as wild type C. albicans (data not shown).
Virulence of the single mutants was tested in a Galleria
mellonella larvae model of infection. In this model all
larvae infected with the wild type strain succumbed to
infection by day 2, whereas 75% of larvae infected with
the pmr1Δ mutant, which displays a gross defect in gly-
cosylation, survived to the end of the experiment. How-
ever, none of the MNN1 family mutants displayed a
virulence defect, demonstrating that none of the individ-
ual family members are required for virulence in this
model. Because the mnn14Δ mutant displayed an altered
phenotype in vitro we tested its virulence in a murine
model of disseminated infection; in addition the mnn1Δ
and mnn12Δ mutants were also tested. The mnn1Δ and
mnn12Δ null mutants were unaltered in virulence. How-
ever, the mnn14Δ null mutant was clearly attenuated in
virulence (log-rank test; p < 0.001) with all mice surviv-
ing to the end of the experiment at 28 days compared to
a median survival time of 9 days for the wild type con-
trol. Mice infected with the mnn14Δ null mutant also
displayed a clear reduction in tissue burdens at 28 days
compared to that seen post-mortem following infection
with the wild type strain, with a >2 log reduction in kidney
burdens (log10 CFU/g 4.0 ± 1.3 cf. 6.5 ± 0.4) and a 1 log re-
duction in the brain (log10 CFU/g 3.3 ± 0.9 cf. 4.3 ± 0.4).
Hence the mnn14Δ null mutant was significantly at-
tenuated in virulence in the murine model of systemic
candidiasis.
Conclusion
The C. albicans cell wall is the immediate point of contact
between the invading fungus and the host, and previous
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tures as important in the host-pathogen interaction and
virulence. In this study, we present the first analysis of the
C. albicans MNN1 gene family, which is predicted to en-
code capping enzymes involved in the terminal stages of
glycosylation. We generated single null mutants in the six
members of the C. albicans MNN1 gene family. The ma-
jority of the mutants generated, with the exception of the
mnn14Δ null mutant, demonstrated no discernible changeTable 3 C. albicans strains
Strain Parent strain Genotype
CAI-4 - ura3Δ::imm434/ura3Δ::imm434
SN78 - ura3Δ::imm434/ura3Δ::imm434, leu2Δ/
NGY152 CAI-4 As CAI-4 but RPS1/rps1Δ::CIp10
SBC106 CAI-4 As CAI-4 but MNN1/mnn1Δ::hisG-URA3
SBC107 SBC106 As CAI-4 but MNN1/mnn1Δ::hisG
SBC108 SBC107 As CAI-4 but mnn1Δ::hisG/mnn1Δ::hisG
SBC109 CAI-4 As CAI-4 but MNN12/mnn12Δ::hisG-UR
SBC110 SBC109 As CAI-4 but MNN12/mnn12Δ::hisG
SBC111 SBC110 As CAI-4 but mnn12Δ::hisG/mnn12Δ::h
SBC112 SBC108 As CAI-4 but mnn1Δ::hisG/mnn1Δ::hisG
SBC113 SBC111 As CAI-4 but mnn12Δ::hisG/mnn12Δ::h
SBC114 SBC112 As CAI-4 but mnn1Δ::hisG/mnn1Δ::hisG
SBC115 SBC113 As CAI-4 but mnn12Δ::hisG/mnn12Δ::h
SBC122 SN78 As SN78 but MNN13/mnn13Δ::CmLeu2
SBC123 SN78 As SN78 but MNN14/mnn14Δ::CmLeu2
SBC124 SN78 As SN78 but MNN15/mnn15Δ::CmLeu2
SBC135 SN78 As SN78 but MNN16/mnn16Δ::CmLeu2
SBC126 SBC122 As SN78 but mnn13Δ::CmLeu2/mnn13
SBC127 SBC123 As SN78 but mnn14Δ::CmLeu2/mnn14
SBC128 SBC124 As SN78 but mnn15Δ::CmLeu2/mnn15
SBC129 SBC135 As SN78 but mnn16Δ::CmLeu2/mnn16
SBC130 SBC126 As SN78 but mnn13Δ::CmLeu2/mnn13
SBC131 SBC127 As SN78 but mnn14Δ::CmLeu2/mnn14
SBC132 SBC128 As SN78 but mnn15Δ::CmLeu2/mnn15
SBC133 SBC129 As SN78 but mnn16Δ::CmLeu2/mnn16
SBC163 SBC130 As SN78 but mnn13Δ::CmLeu2/mnn13
SBC164 SBC131 As SN78 but mnn14Δ::CmLeu2/mnn14
SBC165 SBC132 As SN78 but mnn15Δ::CmLeu2/mnn15
SBC166 SBC133 As SN78 but mnn16Δ::CmLeu2/mnn16
SBC161 SBC114 As CAI-4 but mnn1Δ::hisG/mnn1Δ::hisG
SBC162 SBC115 As CAI-4 but mnn12Δ::hisG/mnn12Δ::h
SBC158 NGY152 As NGY152 but HEX1/HEX1-V5-6xHis-N
SBC159 - pmr1Δ::hisG/pmr1Δ::hisG HEX1/HEX1-V
NGY355 - As CAI-4 but pmr1Δ::hisG/pmr1Δ::hisG,
NGY357 As CAI-4 but och1Δ::hisG/och1Δ::hisG,
NGY337 As CAI-4 but mnt1-mnt2Δ::hisG/mnt1-in phenotype potentially due to functional redundancy as
seen with some other C. albicans mannosyltransferase
gene families [9,11,16]. Disruption of MNN14 however led
to both in vitro and in vivo defects. The mnn14Δ null
mutant displayed subtle morphogenesis defects and
hypersensitivity to agents associated with cell wall and gly-
cosylation defects, suggesting altered cell wall structure or
permeability. However, no gross changes in cell wall com-
position or N-glycan extension were identified, althoughReference
[32]
leu2Δ, his1Δ/his1Δ [33]
[35]
-hisG This study
This study
-URA3-hisG This study
A3-hisG This study
This study
isG-URA3-hisG This study
This study
isG This study
, RPS1/rps1Δ::CIp10 This study
isG, RPS1/rps1Δ::CIp10 This study
This study
This study
This study
This study
Δ::CdHIS1 This study
Δ::CdHIS1 This study
Δ::CdHIS1 This study
Δ::CdHIS1 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10, HEX1/HEX1-V5-6xHis-NAT1 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10, HEX1/HEX1-V5-6xHis-NAT1 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10, HEX1/HEX1-V5-6xHis-NAT1 This study
Δ::CdHIS1, RPS1/rps1Δ::CIp10, HEX1/HEX1-V5-6xHis-NAT1 This study
, RPS1/rps1Δ::CIp10, HEX1/HEX1-V5-6xHis-NAT1 This study
isG, RPS1/rps1Δ::CIp10, HEX1/HEX1-V5-6xHis-NAT1 This study
AT1 [36]
5-6xHis-URA3 [36]
RPS1/rps1Δ::CIp10 [8]
RPS1/rps1Δ::CIp10 [7]
mnt2Δ::hisG, RPS1/rps1Δ::CIp10 [11]
Table 4 Oligonucleotides used for strain construction
Primer Sequence (5′-3′) a
MNN1-5H AAGCTTtctacagtggctgttaataatg
MNN1-5S GCATGCgaaaactcatacaattcactaag
MNN1-3A GGTACCtgcttactcaagtgttggtg
MNN1-3B GAGCTCgttagtggcttgtatcaaagg
MNN12-5H AAGCTTatcataacacgttcgttcagc
MNN12-5S GCATGCtgacagatcatcgtcttcatc
MNN12-3A GGTACCatgccattattccaccaatgg
MNN12-3B GAGCTCgttgtgactgtggctccac
MNN13-KO-F gttgactttgaagagccactgtatactttccctaagacggtgctatttgaaaac
aacaacaatttggatgatttattatGCTCGGATCCACTAGTAACG
MNN13-KO-R ttaatattttccaacccatacatctcctaagtaattgaaatatgcaatttcttcagg
ggtatactcaaccaataaaccaCCAGTGTGATGGATATCTGC
MNN14-KO-F atgcattttatttggcaatcacaagccaattctggattaatactaaaaaat
gaattatcactgacatcaagtatcccccGCTCGGATCCACTAGTAACG
MNN14-KO-R ctataaataattatatcccctcatccatatctccccaagctttttaaaatgttctatt
tcctctggtgaataattaattCCAGTGTGATGGATATCTGC
MNN15-KO-F cgtataagggaacttttacatgatagtgaaaaatttgatctcgagagtctaaag
caagctagcttggagataagaaaagGCTCGGATCCACTAGTAACG
MNN15-KO-R ctttatccgaaccagttccaagtttctcagtttctaatttaacttttggcttcattttg
gatccaccagtgtgccatatCCAGTGTGATGGATATCTGC
MNN16-KO-F gaagttccatcttaaaagatatgtcatagttacttcaatactactatctttt
ttcttattattcagacgacaatttcttGCTCGGATCCACTAGTAACG
MNN16-KO-R ttaatcttgtaaccaaatttcaattaatttcttatattttttttgtaaactttgttcaa
cattaatagataatcctctaCCAGTGTGATGGATATCTGC
a Gene-specific sequences are lowercase.
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This extension of phosphomannan in the mnn14Δ null
mutant could be a compensatory mechanism for its ab-
sence, through an increase in the expression, or activity, of
other mannosyltransferases. Alternatively Mnn14 could
potentially act as a capping enzyme to terminate extension
similar to the proposed role of MNN1 in S. cerevisiae [30].
Although the mnn14Δ null mutant only displayed subtle
cell wall defects this mutant did display a severe defect in
virulence in a murine infection model, apparent both in
terms of overall survival and associated tissue burdens.
This virulence defect was not associated with differences
in the induction of inflammatory responses, as no defect
was seen in the TNFα and IL-6 host cytokine production
in vitro, which suggests that the virulence defect may not
be due to an alteration of the host response. Overall,
therefore, the MNN1 family appears to display redun-
dancy, with the exception of MNN14, which may there-
fore play a distinct role either in the synthesis of specific
epitopes or in the modification of a discrete protein(s) re-
quired for virulence and the host-pathogen interaction.
Methods
Strains, media and culture conditions
C. albicans strains were grown in yeast and hyphal forms
as described previously [7]. To induce β-N-acetylhexosa-
minidase expression strains were grown in SC-GlcNAc
(0.67% yeast nitrogen base, 0.079% complete supplement
mixture, 25 mMN-acetylglucosamine). Biofilm formation
in the mutants was assessed using a tetrazolium salt
(XTT) reduction assay following growth in SC medium
for 24 and 48 h [31]. Null mutants in MNN1 (orf19.4279)
and MNN12 (orf19.4900) were generated by the “Ura-
blaster” protocol in strain CAI-4 [32]. Briefly, the 5′ and
3′ regions of homology were amplified by PCR (MNN1 5′
primer pair MNN1-5H/5S, 3′ primer pair MNN1-3A/3B;
MNN12 5′ primer pair MNN12-5H/5S, 3′ primer pair
MNN12-3A/3B) and cloned into the HindIII/SphI and
Asp718/BanII sites of the disruption vector pMB-7 re-
spectively. The ura-blaster cassettes were then released by
digestion with HindIII and BanII and genes disrupted in
CAI-4 by sequential gene replacement and recycling of
the URA3 marker by selection on SD medium plus 5-
fluoroorotic acid (1 mg/ml) and uridine (50 μg/ml). Single
null mutants in the other family members, MNN13
(orf19.4270), MNN14 (orf19.6996) MNN15 (orf19.753)
and MNN16 (orf19.6313), were generated through PCR
mediated disruption [33]. Primers (MNNxx-KO-F/-R)
were designed to contain 70 bp homology to the gene of
interest, and disruption cassettes amplified from pSN40
(C. maltosa LEU2) and pSN52 (C. dubliniensis HIS1).
Amplified cassettes were then sequentially transformed
into strain SN78 to generate null mutants. The URA3
marker was integrated at the RPS1 locus in all mutants bytransformation with the StuI-digested CIp10 vector [34],
to avoid problems associated with its expression [35]. To
control against second site mutations two independently
constructed null mutants were generated and screened for
each member of the family. Strain genotypes and the
oligonucleotides used in their construction are listed in
Tables 3 and 4. The wild type strain used for phenotypic
studies throughout was NGY152 [35] derived from CAI-4
with the CIp10 vector integrated at the RPS1 locus.
Cell wall and glycosylation analysis
Null mutants were screened for sensitivity to cell wall
stressing agents by the microdilution method as previ-
ously reported [7]. Briefly, standardised inocula (A600 =
0.01) of strains in YEPD medium were incubated with cell
wall stressing agents, across a range of doubling dilutions,
for 16 h at 30°C and the A600 was determined. The agents
tested (maximum concentrations in parentheses) included
Calcofluor White (500 μg/ml), Congo Red (500 μg/ml),
SDS (0.1%), hygromycin B (500 μg/ml), NaCl (2 M) and
tunicamycin (50 μg/ml). Phosphomannan content and
N-glycosylation status were determined by Alcian Blue
binding assays and β-N-acetylhexosaminidase (Hex1)
native PAGE zymograms as reported elsewhere [7]. In
addition the N-glycosylation status was assessed by Western
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tagged Hex1 protein as a glycosylation reporter as de-
scribed previously [36]. Cell wall carbohydrate compos-
ition was determined by acid hydrolysis of the cell wall
carbohydrate polymers and quantification of constituent
monosaccharides following high performance anion ex-
change chromatography [37]. Finally, for the analysis of
phosphomannan and O-linked mannan, strains were la-
belled with D-[2-3H] mannose, mannans released through
mild acid treatment and β-elimination respectively and
separated through thin layer chromatography (TLC) [7].
Virulence assays
Isolation of human peripheral blood mononuclear cells
(PMBCs) and cytokine stimulation assays were carried
out as described previously [15]. For the wax moth lar-
vae infection model groups of 8 larvae were infected
with 3×105 CFU of C. albicans through the last left pro-
leg and survival monitored over 7 days at 37°C. To test
virulence in a murine infection model groups of 6 female
BALB/c mice were intravenously challenged with 3.6×104
CFU/g (body weight) C. albicans and monitored over
28 days. Animals showing signs of illness or disease were
humanely terminated and recorded as dying the following
day, and those surviving the course of the experiment
were terminated on day 28. The kidneys and brain were
aseptically removed post-mortem, homogenised, and tis-
sue burdens determined by viable counting. Experiments
were conducted under the terms of a UK Home Office li-
cence and were approved by the University of Aberdeen
Ethical Review Committee.
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